ODI Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is July - June.

Millions SEK. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Apr '25 Apr 3, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019
Market Capitalization	43	110	84	82	68	85	Upgrade
Market Cap Growth	-53.57%	30.91%	1.85%	21.08%	-20.36%	-	Upgrade
Enterprise Value	37	104	80	73	52	63	Upgrade
Last Close Price	2.68	7.20	5.50	5.40	4.46	5.60	Upgrade
PS Ratio	1.98	4.92	600.26	262.63	-	-	Upgrade
PB Ratio	95.85	54.76	32.54	8.87	4.17	4.25	Upgrade
P/TBV Ratio	95.85	54.76	32.54	8.87	4.17	4.25	Upgrade
EV/Sales Ratio	1.73	4.65	573.75	233.92	-	-	Upgrade
EV/EBITDA Ratio	-	240.49	-	-	-	-	Upgrade
EV/EBIT Ratio	-	242.14	-	-	-	-	Upgrade
Asset Turnover	3.08	2.18	0.02	0.02	-	-	Upgrade
Inventory Turnover	-	-	0.77	0.34	-	-	Upgrade
Quick Ratio	1.04	1.14	1.30	6.84	26.74	26.33	Upgrade
Current Ratio	1.07	1.20	1.46	8.49	29.00	26.53	Upgrade
Return on Equity (ROE)	-324.80%	-24.84%	-116.63%	-56.64%	-21.89%	-41.15%	Upgrade
Return on Assets (ROA)	-26.68%	2.62%	-45.57%	-32.91%	-13.13%	-24.35%	Upgrade
Return on Capital (ROIC)	-150.27%	11.70%	-71.95%	-35.24%	-13.62%	-25.57%	Upgrade
Return on Capital Employed (ROCE)	-	21.40%	-	-	-	-	Upgrade
Earnings Yield	-944.74%	-0.52%	-8.24%	-8.81%	-5.87%	-5.82%	Upgrade
FCF Yield	-	-3.49%	-6.10%	-8.98%	-8.93%	-5.60%	Upgrade
Buyback Yield / Dilution	-37.80%	0.76%	-1.69%	1.52%	-11.10%	-10.04%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.